# Larimar Therapeutics, Inc.: Form DEF 14A, filed Apr 12, 2022

- Company: [Larimar Therapeutics, Inc.](/companies/lrmr.md) (CIK 1374690)
- Form: DEF 14A
- Filed: 2022-04-12
- Accepted by EDGAR: Apr 12, 2022, 10:06 ET
- Period: 2022-05-10
- Accession: 0001193125-22-102289
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1374690/000119312522102289/d301043ddef14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1374690/000119312522102289/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1374690/000119312522102289/d301043ddef14a.htm

Filed Apr 12, 2022.
Source: SEC EDGAR, the filing index for accession 0001193125-22-102289. Last ingested by Listed: Oct 24, 2026, 15:12 ET. No prices; not investment advice.